About SERPIN PHARMA INC
Serpin Pharma develops targeted therapeutics to enhance the body’s natural immune response, reducing inflammation and restoring immune balance. Their lead therapeutic, SP16, is a modified fragment of a natural SERPIN protein with applications in treating inflammatory conditions.
Development of targeted therapeutics to reduce inflammation and restore immune balanceCreation of SP16, a modified SERPIN protein fragment with enhanced affinity to the LRP1 receptorPatent estate covering Composition of Matter and Use of SERPIN Peptide Drug and AnalogsDevelopment of SP16 analogs with extensive modifications outside of the binding motif
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to SERPIN PHARMA INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.